Congenital cytomegalovirus (cCMV) is the most common infectious cause of childhood hearing loss that is not genetic. About 1 in 200 babies is born with it. Most look fine in the nursery. About 1 in 5 of those infants will have hearing loss or a developmental effect then or later.
This week two things landed together. On 21 September the American Academy of Pediatrics published a clinical report, Care of the Infant With Congenital Cytomegalovirus Infection, that takes a position on how to find those babies. On 30 September a Cleveland Clinic NICU study in the same journal reported that testing every NICU infant found about twice as many cases as testing only the babies who failed a hearing screen.
Background
For years states split into two camps. Minnesota and Connecticut require a CMV test on every newborn. About 14 other states test after a failed hearing screen. The rest leave it to hospitals. Hearing-targeted screening is cheaper and misses fewer well babies. It also misses infants whose first hearing test is normal and who later lose hearing because of CMV.
The AAP report reviews that trade-off. It does not call for every U.S. newborn to be tested tomorrow. It endorses hearing-targeted plus expanded testing: test babies who do not pass newborn hearing screening, and also test babies with physical findings tied to cCMV. The authors framed that as a balance of individual health, equity, and system cost.
What changed
Until this report the AAP had not picked a screening stance. The same issue of Pediatrics now holds both the clinical report and the Cleveland Clinic NICU numbers. Universal NICU screening doubled detection versus hearing-targeted screening alone. That is not the same as a whole-birth-hospital universal program, but it is the first large U.S. signal in a high-risk ward that targeted-only screening leaves cases on the table.
Diagnosis in the first three weeks of life matters because antiviral treatment, when a clinician decides it is indicated, is time-limited. A later test cannot always tell congenital infection from a CMV cold the baby caught after birth.
Competing viewpoints
Universal-screening advocates say hearing-targeted programs systematically miss the quiet majority. Cost-and-capacity skeptics say saliva or urine PCR on every baby needs lab contracts, follow-up audiology, and a plan for the 80 percent of infected infants who stay well. Equity arguments cut both ways: targeted programs can skip hospitals that serve families least able to return for later hearing checks; universal programs can flood those same clinics with results they cannot act on.
Federal vaccine and newborn-screening politics this year make a sudden national mandate unlikely. State legislatures and hospital systems will move first.
What parents can do this week
- If your newborn did not pass a hearing screen, ask whether a CMV test was sent in the first three weeks.
- If your baby is in a NICU, ask whether that unit uses targeted-only or broader CMV testing.
- If you are pregnant, CMV prevention is still ordinary hygiene: do not share cups or utensils with toddlers, wash hands after diaper changes. That is not a guarantee. It is the evidence-based list.
- This is not medical advice. Screening and treatment decisions belong with your obstetric and pediatric clinicians.
What to watch next
Whether more states copy Minnesota and Connecticut. Whether NICUs outside Cleveland adopt unit-wide testing. Whether the AAP later tightens or loosens “expanded” criteria once more hospitals publish detection numbers.
Official reading: AAP news release on the clinical report; CDC congenital CMV page; Cleveland Clinic / Pediatrics study coverage dated 30 September 2026.
Comments (0)
No comments yet.
Sign in to comment.